These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 16465411

  • 41. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
    Ikeda S, Ishizaki Y, Shimizu Y, Fujimori M, Ojima Y, Okajima M, Sugino K, Asahara T.
    Int J Oncol; 2002 Mar; 20(3):463-6. PubMed ID: 11836555
    [Abstract] [Full Text] [Related]

  • 42. Nuclear accumulation of beta-catenin without an additional somatic mutation in coding region of the APC gene in hepatoblastoma from a familial adenomatous polyposis patient.
    Inukai T, Furuuchi K, Sugita K, Uno K, Ooi A, Sasaki F, Hamada J, Moriuchi T, Nakazawa S.
    Oncol Rep; 2004 Jan; 11(1):121-6. PubMed ID: 14654913
    [Abstract] [Full Text] [Related]

  • 43. A novel tissue-based ß-catenin gene and immunohistochemical analysis to exclude familial adenomatous polyposis among children with hepatoblastoma tumors.
    Dubbink HJ, Hollink IHIM, Avenca Valente C, Wang W, Liu P, Doukas M, van Noesel MM, Dinjens WNM, Wagner A, Smits R.
    Pediatr Blood Cancer; 2018 Jun; 65(6):e26991. PubMed ID: 29446530
    [Abstract] [Full Text] [Related]

  • 44. Mutations of beta-catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis.
    Park JY, Park WS, Nam SW, Kim SY, Lee SH, Yoo NJ, Lee JY, Park CK.
    Liver Int; 2005 Feb; 25(1):70-6. PubMed ID: 15698401
    [Abstract] [Full Text] [Related]

  • 45. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
    Schmitt-Graeff A, Ertelt-Heitzmann V, Allgaier HP, Olschewski M, Nitschke R, Haxelmans S, Koelble K, Behrens J, Blum HE.
    Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
    [Abstract] [Full Text] [Related]

  • 46. Mutations and elevated transcriptional activity of conductin (AXIN2) in hepatoblastomas.
    Koch A, Weber N, Waha A, Hartmann W, Denkhaus D, Behrens J, Birchmeier W, von Schweinitz D, Pietsch T.
    J Pathol; 2004 Dec; 204(5):546-54. PubMed ID: 15538750
    [Abstract] [Full Text] [Related]

  • 47. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
    Huang SC, Ng KF, Yeh TS, Chang HC, Su CY, Chen TC.
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
    [Abstract] [Full Text] [Related]

  • 48. Genetic alteration of the beta-catenin gene (CTNNB1) in human lung cancer and malignant mesothelioma and identification of a new 3p21.3 homozygous deletion.
    Shigemitsu K, Sekido Y, Usami N, Mori S, Sato M, Horio Y, Hasegawa Y, Bader SA, Gazdar AF, Minna JD, Hida T, Yoshioka H, Imaizumi M, Ueda Y, Takahashi M, Shimokata K.
    Oncogene; 2001 Jul 12; 20(31):4249-57. PubMed ID: 11464291
    [Abstract] [Full Text] [Related]

  • 49. Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam.
    Anna CH, Sills RC, Foley JF, Stockton PS, Ton TV, Devereux TR.
    Cancer Res; 2000 Jun 01; 60(11):2864-8. PubMed ID: 10850429
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations.
    Audard V, Grimber G, Elie C, Radenen B, Audebourg A, Letourneur F, Soubrane O, Vacher-Lavenu MC, Perret C, Cavard C, Terris B.
    J Pathol; 2007 Jul 01; 212(3):345-52. PubMed ID: 17487939
    [Abstract] [Full Text] [Related]

  • 52. Genotype-phenotype relationships in hepatocellular tumors from mice and man.
    Stahl S, Ittrich C, Marx-Stoelting P, Köhle C, Altug-Teber O, Riess O, Bonin M, Jobst J, Kaiser S, Buchmann A, Schwarz M.
    Hepatology; 2005 Aug 01; 42(2):353-61. PubMed ID: 15965925
    [Abstract] [Full Text] [Related]

  • 53. β-Catenin mutations in 2 nested stromal epithelial tumors of the liver--a neoplasia with defective mesenchymal-epithelial transition.
    Assmann G, Kappler R, Zeindl-Eberhart E, Schmid I, Häberle B, Graeb C, Jung A, Müller-Höcker J.
    Hum Pathol; 2012 Nov 01; 43(11):1815-27. PubMed ID: 22749188
    [Abstract] [Full Text] [Related]

  • 54. Significance of beta-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation.
    Kawauchi S, Liu XP, Kawasaki K, Hirakawa T, Amada S, Furuya T, Oga A, Sasaki K.
    J Pathol; 2004 Nov 01; 204(3):268-76. PubMed ID: 15476271
    [Abstract] [Full Text] [Related]

  • 55. beta-Catenin and met deregulation in childhood Hepatoblastomas.
    Ranganathan S, Tan X, Monga SP.
    Pediatr Dev Pathol; 2005 Nov 01; 8(4):435-47. PubMed ID: 16211454
    [Abstract] [Full Text] [Related]

  • 56. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L.
    Transl Res; 2007 Nov 01; 150(5):281-94. PubMed ID: 17964517
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer.
    Suriano G, Vrcelj N, Senz J, Ferreira P, Masoudi H, Cox K, Nabais S, Lopes C, Machado JC, Seruca R, Carneiro F, Huntsman DG.
    Genes Chromosomes Cancer; 2005 Mar 01; 42(3):238-46. PubMed ID: 15609344
    [Abstract] [Full Text] [Related]

  • 60. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D, Moreno-Bueno G, Sánchez-Estévez C, Bañón-Rodríguez I, Hernández-Cortés G, Hardisson D, Palacios J.
    Hum Pathol; 2006 Aug 01; 37(8):1042-9. PubMed ID: 16867867
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.